| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.21 | 0.2 |